For instance: people with obesity are more likely to develop type 2 diabetes people with obesity are at an increased riskof developing Alzheimers later in life people with type 2 diabetes are also more likely to develop Alzheimers disease Alzheimers disease is associated with insulin resistance in the brain, with some scientists referring to Alzheimers as type 3 diabetes obesity, type 2 diabetes, and Alzheimers all involve inflammation, and GLP-1 agonists have an anti-inflammatory effect studies in animal models of dementiahave shown that GLP-1 agonists can protect rats brains from damage
GLP-1 agonist medications, in turn, work by stimulating and mimicking the actions of natural GLP-1 hormones
Enhances physical and mental endurance *
Peptides do, however, have a common biological weakness
Edgerton 2002
These cells interact bidirectionally with resident immune cells microglia and astrocytes, participating in antigen presentation by antigen-presenting cells, activation of T cells, and promotion of lymphatic system circulation in cerebral spinal fluid (60)